摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-Cyclopentylpropyl methanesulfonate | 197146-48-8

中文名称
——
中文别名
——
英文名称
3-Cyclopentylpropyl methanesulfonate
英文别名
——
3-Cyclopentylpropyl methanesulfonate化学式
CAS
197146-48-8
化学式
C9H18O3S
mdl
——
分子量
206.306
InChiKey
UBJYDSDQCTYWGA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.6
  • 重原子数:
    13
  • 可旋转键数:
    5
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    51.8
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    3-Cyclopentylpropyl methanesulfonate 在 sodium azide 作用下, 以 二甲基亚砜 为溶剂, 生成 1-(cyclopentyl)-3-propylazide
    参考文献:
    名称:
    Practical chemoenzymatic synthesis of a 3-pyridylethanolamino β3 adrenergic receptor agonist
    摘要:
    A chemoenzymatic synthesis of beta(3) agonist 1 suitable for large scale preparation is described. The key chiral 3-pyridylethanolamine intermediate (R)-7 was prepared via an improved Neber rearrangement and a yeast-mediated asymmetric reduction. The tetrazolone fragment of the molecule was constructed via a dipolar cycloaddition between 1-(cyclopentyl)-3-propylazide and p-chlorosulfonyl phenylisocyanate. Sulfonamide coupling of these two intermediates under Shotten-Baumann conditions, followed by a borane reduction of the amide afforded 1 in 20-32% overall yield from 3-acetylpyridine, (C) 1999 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0040-4039(99)01353-2
  • 作为产物:
    参考文献:
    名称:
    Practical chemoenzymatic synthesis of a 3-pyridylethanolamino β3 adrenergic receptor agonist
    摘要:
    A chemoenzymatic synthesis of beta(3) agonist 1 suitable for large scale preparation is described. The key chiral 3-pyridylethanolamine intermediate (R)-7 was prepared via an improved Neber rearrangement and a yeast-mediated asymmetric reduction. The tetrazolone fragment of the molecule was constructed via a dipolar cycloaddition between 1-(cyclopentyl)-3-propylazide and p-chlorosulfonyl phenylisocyanate. Sulfonamide coupling of these two intermediates under Shotten-Baumann conditions, followed by a borane reduction of the amide afforded 1 in 20-32% overall yield from 3-acetylpyridine, (C) 1999 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0040-4039(99)01353-2
点击查看最新优质反应信息

文献信息

  • [EN] PROCESS FOR THE PREPARATION OF A beta 3-AGONIST<br/>[FR] PROCEDE DE PREPARATION D'UN AGONISTE DE beta 3
    申请人:MERCK & CO., INC.
    公开号:WO1997034880A1
    公开(公告)日:1997-09-25
    (EN) 3-Cyclopentylpropylazide and $i(p)-chlorosulfonylphenyl-isocyanate undergo cycloaddition to form 1-cyclopropyl-4-($i(p)-chloro-sulfonylphenyl) tetrazone-5-one, a key intermediate in the synthesis of an important $g(b)3-agonist.(FR) 3-cyclopentylpropylazide et $i(p)-chlorosulfonylphényl-isocyanate subissent un apport cyclique, de sorte que du 1-cyclopropyle-4-($i(p)-chlorosulfonylphényle)tétrazone-5-one soit produit, intermédiaire indispensable dans la synthèse d'un agoniste important de $g(b)3.
    3-环戊基丙基叠氮化物和$p$-氯磺酰基苯基异氰酸酯发生环加成反应,形成1-环丙基-4-($p$-氯磺酰基苯基)四唑-5-酮,是合成重要的$g(b)3-激动剂的关键中间体。
  • Cyclic aminophenyl sulfamate derivative
    申请人:Takegawa Shigehiro
    公开号:US20060189625A1
    公开(公告)日:2006-08-24
    This invention provides cyclicamino-phenyl sulfamate derivatives represented by a formula wherein each of R 1 and R 2 stands for hydrogen or lower alkyl; each of R 3 and R 4 stands for hydrogen, halogen, cyano or the like; A stands for nitrogen or CH; B stands for CH 2 , SO 2 , CO, optionally substituted phenyl or the like; and R 5 stands for alkyl, phenyl, amino or the like, or salts thereof which exhibit excellent steroid sulfatase inhibitory activity and are useful for prevention or treatment of diseases associated with steroids such as estrogen, androgen and the like.
    本发明提供了一种循环氨基苯磺酰胺衍生物,其表示为以下式子: 其中,R1和R2中的每一个代表氢或低碳基;R3和R4中的每一个代表氢、卤素、氰或类似物;A代表氮或CH;B代表CH2、SO2、CO、可选取代的苯基或类似物;R5代表烷基、苯基、氨基或类似物,或其盐,具有出色的类固醇磺酸酶抑制活性,可用于预防或治疗与雌激素、雄激素等类固醇相关的疾病。
  • CYCLIC AMINOPHENYL SULFAMATE DERIVATIVE
    申请人:ASKA Pharmaceutical Co., Ltd.
    公开号:EP1627871B1
    公开(公告)日:2010-04-14
  • US5705653A
    申请人:——
    公开号:US5705653A
    公开(公告)日:1998-01-06
  • US7449466B2
    申请人:——
    公开号:US7449466B2
    公开(公告)日:2008-11-11
查看更多